EMCDDA Home
  • EN
Search

Figure TDI-1. Trend in estimated number of new clients entering treatment by selected primary drugs, 2006–11

Part (i) Percentage by primary drug

 
 
Primary drug200620072008200920102011
Related links:
Heroin34.735.833.030.227.526.5
Cocaine22.422.223.921.920.419.6
Cannabis28.829.230.035.037.638.5
Other stimulants6.36.55.74.96.67.4
Other drugs7.76.27.47.98.08.1
Statistical bulletin 2013
See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Notes:

Missing data were interpolated by assigning for the respective country the value for most recent year available (interpolations are for year 2011 only). Altogether, 3.5% of the data points and 8.0% of the number of clients were interpolated. In 2011 the percentage of not known / missing cases for primary drug were of about 9% of all the clients entering in treatment for the first time in their life. For not known / missing cases in the previous years please see Figure TDI - 1 (part ii).

Countries included: Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Hungary, Netherlands, Austria, Portugal, Romania, Slovakia, Slovenia, Finland, Sweden, United Kingdom, Croatia and Turkey.

Sources:

Reitox national reports 2012

Primary drug 2006 2007 2008 2009 2010 2011
Heroin 34.7 35.8 33.0 30.2 27.5 26.5
Cocaine 22.4 22.2 23.9 21.9 20.4 19.6
Cannabis 28.8 29.2 30.0 35.0 37.6 38.5
Other stimulants 6.3 6.5 5.7 4.9 6.6 7.4
Other drugs 7.7 6.2 7.4 7.9 8.0 8.1

tdifig1a

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 08 May 2013